Double-balloon enteroscopy for the detection of GIST in a patient with neurofibromatosis type 1.
Li-Lianagzi GuoJie-Li ChenLi-Sheng WangJun YaoPublished in: Revista espanola de enfermedades digestivas (2024)
NF1 is an autosomal dominant hereditary disease, with a prevalence of at least 1 in 4000-5000 population. The diagnosis criteria of NF1 included typical manifestations such as café-au-lait spots, frecking in the axilla or inguinal region, multiple neurofibromas, Lisch nodeules, and distinctive osseous lesions. Genetic testing shows NF1 mutation. It is essential for tumor surveillance in NF1 patients because their life expectancy is about 54 years due to malignancy. A case of NF-1 patient receive laparoscopic small bowel resection and finally diagnosed as adenocarcinoma and ganglioneuroma. About 25% of NF1 patients had GISTs , most of them were asymptomatic and some may manifest with abdominal pain, bowel obstruction, or gastrointestinal bleeding. CT and MRI are commonly used imaging modalities for GIST in NF1, while they may be negative sometimes. As DBE a more practical and non-invasive method now, we consider it is a valuable method for screening and early detecting small intestine disease for NF1 patients.
Keyphrases
- signaling pathway
- lps induced
- end stage renal disease
- oxidative stress
- nuclear factor
- ejection fraction
- chronic kidney disease
- magnetic resonance imaging
- small bowel
- prostate cancer
- inflammatory response
- early stage
- toll like receptor
- squamous cell carcinoma
- patient reported outcomes
- computed tomography
- high resolution
- immune response
- contrast enhanced
- case report
- photodynamic therapy
- gold nanoparticles
- radical prostatectomy
- radiation therapy
- minimally invasive
- sentinel lymph node
- quantum dots